Corcept Therapeutics (CORT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 106,140 | 101,418 | 112,512 | 106,011 | 94,181 |
| Depreciation Amortization | -6,766 | 4,829 | 8,559 | 2,237 | 2,171 |
| Income taxes - deferred | -29,493 | -33,905 | 4,346 | 14,089 | 16,877 |
| Accounts receivable | -10,066 | -3,432 | -1,427 | -6,270 | -2,340 |
| Accounts payable and accrued liabilities | 5,778 | 4,757 | -3,597 | 3,161 | -735 |
| Other Working Capital | 8,218 | 5,539 | -466 | -5,357 | -4,687 |
| Other Operating Activity | 53,228 | 41,117 | 47,965 | 38,099 | 30,650 |
| Operating Cash Flow | $127,039 | $120,323 | $167,892 | $151,970 | $136,117 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 91,045 | -113,914 | 136,595 | 302,089 | 182,295 |
| PPE Investments | -139 | -413 | -469 | -1,238 | -1,088 |
| Purchase Of Investment | N/A | N/A | N/A | -420,114 | -299,035 |
| Investing Cash Flow | $90,906 | $-114,327 | $136,126 | $-119,263 | $-117,828 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 5,811 | 4,381 | 16,229 | 23,226 | 8,419 |
| Common Stock Repurchased | -145,428 | N/A | -295,985 | -9,945 | -30,975 |
| Other Financing Activity | -9,106 | -21,665 | -22,835 | -1,067 | -6,089 |
| Financing Cash Flow | $-148,723 | $-17,284 | $-302,591 | $12,214 | $-28,645 |
| Beginning Cash Position | 66,329 | 77,617 | 76,190 | 31,269 | 41,625 |
| End Cash Position | 135,551 | 66,329 | 77,617 | 76,190 | 31,269 |
| Net Cash Flow | $69,222 | $-11,288 | $1,427 | $44,921 | $-10,356 |
| Free Cash Flow | |||||
| Operating Cash Flow | 127,039 | 120,323 | 167,892 | 151,970 | 136,117 |
| Capital Expenditure | -139 | -413 | -469 | -1,238 | -1,088 |
| Free Cash Flow | 126,900 | 119,910 | 167,423 | 150,732 | 135,029 |